T. Rowe Price Associates’s ATI Physical Therapy, Inc. ATIP Stock Holding History

T. Rowe Price Associates’s Portfolio ATIP Stock Details ATIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-282	Closed	-$4K	–	3039
2023 Q1	$4K	Hold	282	–	–	﹤0.01%	2911
2022 Q4	$4K	Hold	282	–	–	﹤0.01%	2921
2022 Q3	$15K	Buy	+282	New	+$16K	﹤0.01%	2924

Other funds holding ATIP

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

KCM

Knighthead Capital Management New York $1.52B AUM 19.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GGH

GCM Grosvenor Holdings Chicago, Illinois $901M AUM 28.6% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates's ATIP Position: Q2 2023 in Review

T. Rowe Price Associates sold out of ATI Physical Therapy, Inc. (ATIP) in Q2 2023, closing a stake of 282 shares — an estimated $4K sold.

T. Rowe Price Associates first reported a position in ATIP in Q3 2022 and held it in 3 quarters. The position peaked at $15K in Q3 2022. 37 funds tracked by Wall St. Rank hold ATIP as of Q2 2023.

T. Rowe Price Associates reported no remaining ATI Physical Therapy, Inc. position as of Q2 2023 after selling out during the quarter.
T. Rowe Price Associates sold 282 ATI Physical Therapy, Inc. shares in Q2 2023, an estimated $4K.
T. Rowe Price Associates first reported a position in ATI Physical Therapy, Inc. in Q3 2022 and held it in 3 quarters.
T. Rowe Price Associates's ATI Physical Therapy, Inc. position peaked at $15K in Q3 2022.
37 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.